Case type IVF & Fertility Treatment Injuries

PGT-M Testing Errors

A rendering of DNA double helix strands against a dark blue background.

You used IVF and PGT-M to avoid passing on a known genetic condition, and now a result, a pregnancy test or your child's diagnosis does not match what you were told. Tell us your story.

CBW Law reviews possible PGT-M testing errors for families across the country. We trace how the test was designed, whose samples were used and how each embryo's result was reported to you. Some outcomes reflect known limits of the test, and we will tell you honestly what we find. Tell Us Your Story. Contacting us does not create an attorney-client relationship.

Tell Us Your Story Call (800) 476-2416

PGT-M lets families who carry a known gene variant test IVF embryos before transfer. Each test is custom-built for one family, often using DNA from relatives, so errors can start long before an embryo is biopsied. Some wrong results come from limits no lab can fully remove. Others come from mislabeled samples, a test built for the wrong variant or a report that was misread or never explained. A PGT-M attorney can help you find out which one happened.

How PGT-M testing works for a known family variant

PGT-M stands for preimplantation genetic testing for monogenic conditions. These are conditions caused by a variant in a single gene, such as cystic fibrosis, sickle cell disease or Huntington's disease1. PGT-M looks for a specific variant already known in your family. It can cover dominant, recessive and X-linked conditions2.

Unlike other embryo tests, PGT-M is built for each family. ASRM calls it the most complex form of PGT because it needs patient-specific counseling, confirmation of the variant, case review and a custom lab test, ideally before the IVF cycle starts3. The usual path looks like this:

  • Genetic counseling about the condition and your options3
  • A lab report confirming the exact gene and variant in your family3
  • DNA samples, often cheek swabs, from you, your partner and relatives of known genetic status3
  • Custom test development, which can take a few weeks to a few months3
  • IVF, embryo biopsy and freezing while the samples are analyzed3
  • A report for each embryo, followed by counseling about what it means3

Most labs track the variant two ways. Direct analysis looks for the variant itself. Linkage analysis follows nearby DNA markers that are inherited along with it, using family samples to learn which markers travel with the affected copy of the gene32. Running both lowers the risk that a missed copy of the gene leads to a wrong answer32.

PGT-M has other uses too. Some families use it to find an embryo that is a tissue match for a sick sibling. Others use it to test embryos for an adult-onset condition without learning their own genetic status3.

How PGT-M differs from PGT-A and PGT-SR

The three tests answer different questions, so their limits and their errors differ4:

  • PGT-M checks for one known gene variant in your family. It does not count chromosomes unless PGT-A is added.
  • PGT-A screens all chromosomes for extra or missing copies. It does not look for a family disease.
  • PGT-SR checks for chromosome imbalances when a parent carries a structural rearrangement, such as a translocation.

PGT-A can often be run on the same biopsy as PGT-M. ASRM notes that adding it may leave fewer embryos to transfer, and that in young patients PGT-A has no proven benefit for live birth rates3.

Where PGT-M errors can happen

PGT-M passes through many hands over many months. A mistake at any step can lead to the wrong answer for an embryo. Problems can arise in:

  • Test development: the wrong gene, variant or inheritance pattern used to design the test
  • Family samples: a relative's sample mislabeled, or a relative's genetic status recorded wrong
  • Sample identification: biopsy tubes swapped or labeled with the wrong embryo number (see sample mix-ups)
  • Analysis: too few informative markers, or contamination that was not caught
  • Interpretation: a recombination or dropout misread as a clear result
  • Reporting: the wrong embryo marked unaffected, or confusing terms like carrier and affected
  • Communication: limits, reduced accuracy or inconclusive results not explained to you

European guidance puts it plainly: results based on family markers are only as accurate as the samples. It says reports should state that accuracy assumes the samples were correctly identified, family relationships are true and relatives' diagnoses are correct5. The same guidance calls for two unique identifiers on each sample and an independent check at high-risk steps5.

Donor eggs or sperm add another step. ASRM says the lab always needs the donor's DNA for PGT-M, and that switching to a new donor means the test must be updated3. A missing donor sample or an outdated test is the kind of gap a PGT-M lawyer looks for.

Standards and guidance for PGT-M testing

In its 2023 committee opinion, ASRM noted that PGT-M is not regulated in the United States, unlike in other countries, and that the current lack of PGT-M-specific U.S. guidelines has led to differences between clinical and laboratory practices3. Professional guidance still sets clear expectations:

What professional guidance expects

Counseling first
Patients should have genetic counseling about the condition and all reproductive options before PGT-M. Accepting PGT-M should be optional3.
Clear limits
Pretest counseling should cover inconclusive or reduced-accuracy results and limits that can cause diagnostic error3. The work-up report should state test limits and residual risk2.
Known reporting terms
Labs use different words, such as carrier, affected, unaffected and wild type. Clinics should understand how their lab reports results3.
Inconclusive embryos
ESHRE does not recommend transferring PGT-M embryos with no result or an inconclusive result5.
After a misdiagnosis
The center should investigate the cause and change its protocols. Many causes are avoidable with good quality management5.

A family that does everything asked of it, from swabs to counseling, should get a result that was built and reported with the same care.

Where the law stands on PGT-M errors

Claims over PGT-M errors generally depend on state law, the contracts you signed and the facts of your case. State law also differs on claims tied to the birth of a child. Arizona, for example, says a person is not liable for damages in a civil action for wrongful birth or wrongful life, whether the child is born healthy or with a medical condition. That rule does not apply to intentional or grossly negligent acts or omissions6. Other states treat these claims differently, and legal treatment of embryos also varies by jurisdiction.

Because of these differences, an attorney reviewing a PGT-M lawsuit will look closely at where treatment and testing happened, which company did the analysis and what each party promised in writing.

What happens when an embryo is misclassified

An error can run in either direction, and each causes a different kind of harm:

  • An affected embryo is reported as unaffected and transferred
  • An unaffected embryo is reported as affected and discarded or never used (see embryos discarded after genetic testing)
  • A pregnancy faces hard decisions after prenatal testing finds the condition
  • A child is born with the condition the family worked to avoid
  • The family repeats IVF, often with new test development costs
  • Family secrets, such as unexpected parentage, coming to light through relatives' samples3
  • Grief, guilt and strain on the family

The effects can surface at different times. Some families learn of a problem from a prenatal test. Others learn only after birth, or when a frozen embryo is retested years later. The records from each step, and when you learned of the problem, shape what a review can show.

Genetic counseling and confirmatory prenatal testing

Because of known technical limits, ASRM says prenatal testing should be offered for pregnancies after PGT-M to confirm the embryo result3. Chorionic villus sampling or amniocentesis can confirm a PGT-M result with higher accuracy during pregnancy3. ACOG also says a normal or negative embryo test does not ensure a baby without genetic problems4.

Choosing whether to have prenatal testing is a personal decision. ASRM notes these choices can be nuanced and shaped by emotion and how a family sees the risk3. Declining a prenatal test does not cause a lab error. If a test was designed, run or reported wrongly, that mistake belongs to the people who made it, not to the patient. Our page on PGT results and testing limitations explains residual risk across all types of embryo testing.

When to talk to a PGT-M attorney

Consider speaking with a lawyer if:

  • Prenatal or newborn testing found the condition PGT-M was meant to screen out
  • Records list the wrong variant, the wrong relative or the wrong embryo
  • You were never told a result had reduced accuracy
  • An embryo was transferred despite an inconclusive result you did not know about
  • Retesting shows an embryo was misclassified

A claim review compares the test design with the confirmed family variant. It checks every sample's chain of custody, the lab's interpretation and the reports and counseling notes you received.

Who may be responsible for a PGT-M testing error

  • The PGT laboratory that designed the test, analyzed samples and wrote the report
  • The fertility clinic that ordered the test and chose embryos for transfer
  • The embryology lab that performed the biopsy and labeled the tubes
  • A genetic counselor or physician who explained, or failed to explain, the results
  • A diagnostic lab that reported a family member's genetic status

None of these parties is presumed at fault. Their roles depend on the records and agreements in your case.

Filing deadlines for a PGT-M lawsuit

Every claim has a time limit, and some are shorter than people expect. The deadline that applies depends on your state, the type of claim and the facts of your situation.

Do not wait, and do not assume it is too late. Tell us your story as soon as you can, and we will look at the time limits that apply to you.

Tell Us Your Story →

Records that matter in a PGT-M review

Records to request or keep

Genetic testing records

  • The original lab report confirming the family variant
  • PGT-M case review and work-up report
  • Embryo-by-embryo PGT-M results
  • Any retest, prenatal or newborn genetic results

Family and sample records

  • List of relatives who gave samples
  • Sample collection kits and shipping records
  • Donor DNA records, if donor eggs or sperm were used
  • PGT-M consent forms and lab requisitions
  • Genetic counseling notes
  • Embryo transfer and disposition records
  • Messages and emails with the clinic or lab

What happens after you contact CBW Law

Our review process

  1. Tell us your story

    Tell us the condition tested, when testing happened and what you have learned since.

  2. We check deadlines

    We look at where care took place and whether a filing deadline may be near.

  3. We study the testing trail

    With your permission, we gather lab, clinic and counseling records and follow each sample from swab to report.

  4. We give you an honest answer

    We explain whether we see a claim and what it would involve. Contacting us does not mean we will take the case.

Plain English

Medical, Health & Insurance

PGT-M reports mix genetics, lab and billing language. These short definitions may help.

Genetics basics

Monogenic condition
A condition caused by a variant in a single gene1.
Autosomal recessive
A child is affected only with variants in both copies of the gene; parents are usually unaffected carriers1.
Autosomal dominant
One altered copy of the gene is enough to cause the condition1.
Variant of uncertain significance (VUS)
A gene change without enough evidence to call it harmful or harmless3.

PGT-M lab terms

Linkage analysis
Tracking DNA markers next to the gene that are inherited along with the variant3.
Allele dropout (ADO)
Failure to detect one of the two gene copies in a small sample2.
Recombination
An exchange of DNA between paired chromosomes that can separate a marker from the variant2.
Haplotype
A group of DNA markers on one chromosome inherited together2.

Pregnancy testing

Chorionic villus sampling (CVS)
A prenatal diagnostic test of placental tissue that can confirm a PGT-M result3.
Amniocentesis
A prenatal diagnostic test of fluid around the fetus that can confirm a PGT-M result3.

Insurance and billing

Test development fee
A charge for building a family-specific PGT-M test before embryos are tested.
Prior authorization
An insurer's approval needed before some services are covered.
Explanation of benefits (EOB)
An insurer's statement of what was billed, paid and owed.

Questions

Frequently asked PGT-M testing error questions

Answers to common questions from families who used PGT-M.

What is PGT-M, in simple terms?

PGT-M is a test of a few cells from an IVF embryo for one gene variant known to run in your family. It is used for single-gene conditions with dominant, recessive or X-linked inheritance2. The lab builds a custom test for your family before the embryos are tested3.

Why did the lab need DNA from my relatives?

Many PGT-M tests track markers near the gene that are passed down with it. Samples from relatives of known genetic status show which markers travel with the affected copy3. If a relative's sample is mislabeled or their status is recorded wrong, the test can be built on a false map5.

What is allele dropout?

Allele dropout happens when one of the two copies of a gene in a tiny biopsy sample fails to amplify and goes undetected2. It can make an affected embryo look unaffected. Labs reduce this risk by also tracking linked markers3. Dropout is a known limit of the test, so whether it points to an error depends on how the lab designed and checked the test.

My child was born with the condition after PGT-M. Does that mean someone was negligent?

Not by itself. PGT-M has a residual risk even when done correctly, and ACOG says a normal embryo result does not ensure a child without genetic problems4. A review looks for preventable causes, such as a sample mix-up, a test built for the wrong variant or a reporting mistake.

I declined prenatal testing. Does that hurt my claim?

Prenatal testing is offered to confirm PGT-M results, but it is a personal choice3. Declining it does not cause a lab or reporting error. How the law treats that choice can vary by state, so it is a question to raise with a lawyer rather than a reason to stay silent.

What does an inconclusive PGT-M result mean?

It means the lab could not reliably say whether the embryo has the variant. Causes include allele dropout, poor DNA quality, contamination or recombination3. A rebiopsy often yields a result, but not when recombination is the cause3. ESHRE does not recommend transferring PGT-M embryos with an inconclusive result5.

Can PGT-M results be transferred to another lab?

Usually not. ASRM says test development is lab-specific, so switching labs means building the test again, and leftover biopsy DNA typically cannot be moved between labs3. If you changed labs or donors, ask whether the test was updated. ASRM says a new donor requires an updated test3.

Who can be sued for a PGT-M testing error?

It depends on who made the mistake. Possible parties include the PGT lab, the fertility clinic, the embryology lab, the genetic counselor or physician, and a diagnostic lab that tested a relative. No one is presumed responsible. A PGT-M lawyer starts with the records to see where the chain broke.

How long do I have to bring a PGT-M lawsuit?

Every claim has a time limit, and it depends on your state and the facts. Contact us as soon as you can so a lawyer can check the deadline that applies to you.

Tell Us Your Story

PGT-M depends on a long chain of family samples, custom lab work and careful reporting. When a link in that chain breaks, the result can change a family's life.

If a PGT-M result did not hold up, tell us your story. We will look at what happened and explain your options honestly, without promising a particular outcome.

Tell Us Your Story Call (800) 476-2416

This page is general information about PGT-M testing errors. It is not legal or medical advice and does not create an attorney-client relationship. An unsuccessful cycle, a complication, an embryo loss or a testing limitation does not, by itself, establish that anyone was negligent. No outcome can be promised in any case.

Keep reading

PGT-M testing resources

Trusted places to learn about single-gene conditions, embryo testing and genetic counseling.

Patient support

Find a Genetic Counselor, National Society of Genetic Counselors

Search for a genetic counselor near you or by telehealth.

Government

Inheritance Patterns, MedlinePlus Genetics

NIH explainer on dominant, recessive and X-linked conditions.

Professional guidance

Genetic Screening/Testing, ReproductiveFacts.org (ASRM)

ASRM patient resources, including a SART episode on PGT-M.

Professional guidance

Prenatal Genetic Diagnostic Tests, ACOG

What CVS and amniocentesis involve and what results mean.

Patient support

RESOLVE: The National Infertility Association

Support groups and advocacy for people building families.

Apparatus

Sources & Cited Articles

The source material behind each factual, medical and legal statement on this page, numbered to match the markers in the text.

  1. What are the different ways a genetic condition can be inherited?MedlinePlus Genetics, National Library of Medicine · MedlinePlus GeneticsSingle-gene conditions and examples; dominant and recessive inheritance definitions.
  2. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disordersESHRE PGT-M Working Group, Carvalho F, Moutou C, et al. · Human Reproduction Open 2020;2020(3):hoaa018Scope of PGT-M; allele dropout, contamination and recombination as causes of misdiagnosis; haplotyping; residual risk and test limits in the work-up report.
  3. Indications and management of preimplantation genetic testing for monogenic conditions: a committee opinionPractice Committee and Genetic Counseling Professional Group of the American Society for Reproductive Medicine · Fertility and Sterility 2023;120(1):61-71PGT-M process, custom test development and timing; family samples; linkage and direct analysis; allele dropout; inconclusive and reduced-accuracy results; hard-to-test variants; lab-specific tests and donor changes; reporting terms; PGT-M not regulated in the U.S.; counseling and offering prenatal testing; adding PGT-A.
  4. Preimplantation Genetic Testing (Committee Opinion No. 799)American College of Obstetricians and Gynecologists, Committee on Genetics · March 2020, reaffirmed 2025Definitions distinguishing PGT-M, PGT-A and PGT-SR; a normal or negative result does not ensure a newborn without genetic abnormalities.
  5. ESHRE PGT Consortium good practice recommendations for the organisation of PGTESHRE PGT Consortium Steering Committee, Carvalho F, Coonen E, et al. · Human Reproduction Open 2020;2020(3):hoaa021Haplotyping accuracy depends on correct sample identity, true family relationships and correct relative diagnoses; labeling and witnessing; no transfer of inconclusive PGT-M embryos; investigation of misdiagnosis.
  6. Arizona Revised Statutes § 12-719Arizona State Legislature · A.R.S. § 12-719No liability for damages in civil actions for wrongful birth or wrongful life, whether the child is born healthy or not; does not apply to intentional or grossly negligent acts or omissions.

Accountability

Reviewed by

Craig Weiss, founder and managing attorney of CBW Law Firm

Craig Weiss

Managing Attorney · CBW Law

View full profile →

Attorney advertising. The content of this website may be considered attorney advertising under the rules of certain jurisdictions. The information on this website is for general information purposes only and should not be taken as legal advice for any individual case or situation. Viewing this site does not create an attorney-client relationship. Prior results do not guarantee a similar outcome. Statutes, regulations and case law change, and the law differs from state to state.